RayzeBio Inc. is now part of Bristol Myers Squibb. Follow our progress delivering breakthrough therapies through our differentiated radiopharmaceutical platform @Bristol Myers Squibb or www.bms.com

LifeSci Venture Partners

Logos Capital

Vivo Capital

Samsara BioCapital

OrbiMed

Perceptive Advisors

Redmile Group

venBio Partners

Versant Ventures

Ally Bridge Group

Laurion Capital Management

Wellington Management

Sands Capital Ventures

Sofinnova Investments

Soleus Capital

Viking Global Investors

RayzeBio

As of today, RayzeBio, Inc. is officially part of Bristol Myers Squibb! We are excited to continue our mission and look forward to delivering breakthrough therapies through our differentiated radiopharmaceutical platform as part of BMS. Follow our progress Bristol Myers Squibb

We are excited to announce our proposed acquisition by Bristol Myers Squibb. Our leading position in radiopharmaceutical therapeutics coupled with the broad and deep expertise of BMS in oncology allows us to work together to bring forth this next wave of innovation in cancer therapy for patients. 

https://lnkd.in/gTEy-mC4

Look forward to catching up in NY, London, or Miami this month at the Truist, Jefferies London, or Evercore Healthcare conference

https://lnkd.in/gxaTaMTE

RefleXion is a biotechnology company focused on developing a biology-guided radiotherapy system for cancer treatment.

RefleXion

Navidea is a biopharmaceutical company that develops precision diagnostics and radiopharmaceutical agents for cancer and other diseases.

Navidea

CivaTech Oncology is a medical device company focused on developing and commercializing novel brachytherapy solutions for cancer treatment.

CivaTech

Additional information about another competitor.

Additional Competitor

RayzeBio is a biopharmaceutical company focused on developing radiopharmaceutical medicines to defeat cancer. They have a diverse portfolio of radiopharmaceutical drug candidates, ranging from discovery to late-stage clinical programs.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 5, 2024 11:17 AM	27b7b537
public peers	general
news daily refresh	general	Aug 31, 2024 12:20 PM	5adabcd2
news processing daily refresh	general	Aug 30, 2024 3:48 AM	b6e66558
news impact assignment daily	general	Aug 30, 2024 11:59 AM	12b8f7db
news processing basic	general	Mar 5, 2024 11:17 AM	3c7a6352
company summary	general	Aug 30, 2024 7:16 PM	ed2b1210
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Mar 5, 2024 11:17 AM	8bf88931
translate crunchbase fundingrounds	general
peers	general
news basic	general	Mar 5, 2024 11:17 AM	fea8218b
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:RAYZEBIO

RayzeBio